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Summary
Background Antimicrobial misuse is common in low-income and middle-income countries (LMICs), and this practice 
is a driver of antibiotic resistance. We compared community-based antibiotic access and use practices across 
communities in LMICs to identify contextually specific targets for interventions to improve antibiotic use practices.
Methods We did quantitative and qualitative assessments of antibiotic access and use in six LMICs across Africa 
(Mozambique, Ghana, and South Africa) and Asia (Bangladesh, Vietnam, and Thailand) over a 2·5-year study period 
(July 1, 2016–Dec 31, 2018). We did quantitative assessments of community antibiotic access and use through supplier 
mapping, customer exit interviews, and household surveys. These quantitative assessments were triangulated with 
qualitative drug supplier and consumer interviews and discussions.
Findings Vietnam and Bangladesh had the largest proportions of non-licensed antibiotic dispensing points. For mild 
illness, drug stores were the most common point of contact when seeking antibiotics in most countries, except South 
Africa and Mozambique, where public facilities were most common. Self-medication with antibiotics was found to be 
widespread in Vietnam (55·2% of antibiotics dispensed without prescription), Bangladesh (45·7%), and Ghana 
(36·1%), but less so in Mozambique (8·0%), South Africa (1·2%), and Thailand (3·9%). Self-medication was 
considered to be less time consuming, cheaper, and overall, more convenient than accessing them through health-
care facilities. Factors determining where treatment was sought often involved relevant policies, trust in the supplier 
and the drug, disease severity, and whether the antibiotic was intended for a child. Confusion regarding how to 
identify oral antibiotics was revealed in both Africa and Asia.
Interpretation Contextual complexities and differences between countries with different incomes, policy frameworks, 
and cultural norms were revealed. These contextual differences render a single strategy inadequate and instead 
necessitate context-tailored, integrated intervention packages to improve antibiotic use in LMICs as part of global 
efforts to combat antibiotic resistance.
Funding Wellcome Trust and Volkswagen Foundation.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction 
Antibiotic resistance has created an urge for global efforts 
to facilitate appropriate use of antibiotics. Global reports 
on antibiotic resistance have shown that studies are 
needed in low-income and middle-income countries 
(LMICs), where local data are scarce and resistance is 
widespread.1,2 In a report3 quantifying antibiotic exposure 
in children younger than 5 years in eight African LMICs 
between 2006 and 2016, antibiotics were prescribed to 
80·5% (15 480 of 19 231) of children diagnosed with 
respiratory illness, with a large proportion of these 
prescriptions deemed unnecessary. Between 2000 and 
2010, worldwide antibiotic consumption for human use 
increased by 35%, particularly in LMICs, with high levels 
of antibiotic use both inside and outside the formal health-
care system.4 Consumption of broad-spectrum antibiotics 
also increased in LMICs, suggesting increased access and 
a response to an increase in resistance.5 Reducing 
unnecessary use of antibiotics would benefit patients in 
terms of preventing side-effects and in reinforcing global 
efforts to control antibiotic resistance.
A systematic review6 covering 34 studies on factors 
associated with self-medication of antimicrobials in 
LMICs showed that 39% of respondents self-medicate. 
Pharmacies, drug stores, and leftover or borrowed drugs 
were identified as main sources of self-medication. The 
key determinants included severity of illness, economic 
status, past successful antibiotic use and educational 
level. Another review7 covering 15 studies investigating 
factors affecting self-medication of antimicrobials in 
LMICs found a broad range in the prevalence of 
self-medication, from 8% to 93%. Sociocultural 
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determinants of health associated with the structure and 
conditions of the health system, including accessibility, 
affordability, health-care facilities conditions, and health-
seeking behaviour, were found to be the main factors 
affecting self-medication in studied LMICs. A systematic 
review of 85 studies,8 59 of which were done in LMICs, 
found that more than 60% of antibiotics were dispensed 
without a prescription in 49 (83%) of the studies. 
However, there is a considerable heterogeneity in these 
systematic reviews due to an absence of standardised 
criteria for collection of survey data. These studies only 
focused on either the supply or the demand side, were 
limited to adults, used little data from African settings, 
and their methods often risked recall bias.9 Moreover, 
there is a scarcity of comprehensive and contextual 
studies considering local complexities to guide future 
research and support the development of evidence-based 
interventions in promoting appropriate antibiotic use 
across different LMICs.
To fill these research gaps, we aimed to use a 
comparative approach to assess access and use practices 
across communities in six LMICs in Asia (Bangladesh, 
Thailand, and Vietnam) and Africa (Mozambique, 
Ghana, and South Africa) to allow for comparison by 
national income status and identify key drivers through 
both qualitative and quantitative measures.
Methods 
Study design and participants 
Operating from the existing INDEPTH surveillance 
network, a global network of health and demographic 
surveillance sites, this study (the ABACUS project) was 
done in seven communities in six LMICs in Africa 
(Kintampo [rural] and Dodowa [suburban], Ghana; 
Manhiça [rural], Mozambique; and Agincourt [rural], 
South Africa) and Asia (Matlab [rural], Bangladesh; 
Kanchanaburi [urban and suburban], Thailand; and 
Filabavi [rural], Vietnam). For each study site, all possible 
purchase or dispensing points for antibiotics (antibiotic 
suppliers) were included, comprising any formal or 
informal antibiotic supplier from public hospital phar-
macies to street vendors. Country scans for the health-care 
system and antibiotic legal framework are provided in the 
appendix (pp 13–17). Other details on rationale for study 
sites and sample selection are also provided in the 
appendix (pp 1–2) and were published previously.10
We used a mixed-methods approach with in-depth 
interviews and focus group discussions among drug 
Research in context
Evidence before this study
Community-based antibiotic access and use has received less 
attention than prescription behaviours in formal health-care 
settings. We have little understanding of antibiotic use in the 
community, which is considered a key driver of antibiotic 
resistance. We searched PubMed and Google Scholar for articles 
published between Jan 1, 2000, and Jan 12, 2021, and we 
restricted our search to articles published in English that 
reported factors associated with antibiotic use in low-income 
and middle-income countries (LMICs) using the search terms 
“antibiotic”, “self-medication”, and “low- and middle-income 
countries”. We found three systematic reviews covering 
85 studies on antibiotic dispensing without a prescription 
worldwide, of which 59 were published in LMICs, 34 studied 
factors affecting self-medication with antimicrobials in LMICs, 
and 15 investigated factors affecting self-medication with 
antibiotics in LMICs. These studies revealed a high prevalence of 
self-medication. Accessibility, affordability, health-care facility 
conditions, and health-seeking behaviour were found to be the 
main determinants of self-medication in studied LMICs. 
However, there is considerable heterogeneity in the reviewed 
studies due to an absence of standardised criteria for survey 
data collection. The reviewed studies were limited to self-
reporting on questionnaires, focused on either the supply or the 
demand side in households, and provided few insights 
regarding community practices to guide future interventions. 
Furthermore, most studies focused on Asia with little research 
on misuse of antibiotics in Africa, and there is a scarcity of 
comprehensive and contextual studies considering local 
complexities to guide future research and support the 
development of evidence-based interventions in promoting 
appropriate antibiotic use across different LMICs.
Added value of this study
To fill these research gaps, we used a comparative mixed-
method approach to compare community-based antibiotic 
access and use practices across communities in six LMICs in Asia 
(Bangladesh, Thailand, and Vietnam) and Africa (Mozambique, 
Ghana, and South Africa) to allow for comparison by national 
income status and identify supply and demand drivers. Within 
the existing INDEPTH surveillance network, our study was 
powered to identify the contextual complexities and differences 
between countries with different income levels, policy 
frameworks, and cultural norms. The gained insight in 
antibiotic practices in different LMICs could inform the design 
of context-adjusted models for interventions to effectively 
address the usage of antibiotics and contain antibiotic 
resistance in these resource-constrained settings.
Implications of all the available evidence
Our study found common themes reported in previous 
studies in LMICs, but also revealed the diversity and 
complexity of locally specific sociocultural determinants 
affecting antibiotic access and use among studied 
communities in six Asian and African LMICs. The identified 
factors will serve as targets for development of context-
tailored interventions to effectively address the misuse of 
antibiotics and contain antibiotic resistance in LMICs.
See Online for appendix
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suppliers and consumers, household surveys, and 
exit interviews among customers who purchased 
antibiotics. The study was done between July 1, 2016, and 
Dec 31, 2018, in four parts. Part 1 consisted of mapping of 
suppliers and inventories, and part 2 consisted of 
preparatory in-depth interviews and focus group 
discussions with suppliers (16 in-depth interviews 
per site) and community members (16 in-depth 
interviews and six focus group discussions per site). Part 
3 involved quantitative longitudinal household surveys of 
Health and Demographic Surveillance Sites in two 
rounds, during a 1-year period (1100 households per site 
with 5–10% loss to follow-up). This number was adjusted 
for South Africa (600 households per site) and 
Mozambique (650 house holds per site) due to higher 
costs of fieldwork. Simultaneously, community antibiotic 
supply was quantified through standardised customer exit 
interviews at four timepoints over a 1-year study period 
(Aug 1, 2017–July 31, 2018) and synchronised across sites. 
In part 4, to explain any potential discrepancies between 
results from the household survey and the customer exit 
survey, further explanatory in-depth interviews and focus 
group discussions with selected groups (five in-depth 
interviews and two focus group discussions each site) 
were done.10
Antibiotic suppliers aged 18 years or older were eligible 
for qualitative interviews (in-depth interviews and focus 
group discussions). Ideally, each interviewee was affiliated 
with a unique antibiotic supplier, but if fewer than 
16 eligible antibiotic suppliers could be identified at each 
site, a maximum of two employees from the same 
supplier could participate in the in-depth interviews but 
not in the same focus group discussion. Similarly, 
community members aged 18 years or older who were 
willing to share their experience and attitudes toward 
medicines were eligible to participate in qualitative 
interviews (in-depth interviews and focus group 
discussions). Participants from different age categories 
and of different sexes were involved to achieve a more 
informative view. Different targeted populations included 
men and women aged 18–60 years, men and women 
older than 60 years, and mothers who cared for children 
younger than 5 years, due to a higher frequency of health-
care seeking. Two participants from the same household 
were avoided. Community members who participated in 
in-depth interviews were excluded from focus group 
discussion and vice versa. For the household surveys, 
households that already participated in an ongoing health 
and demographic surveillance system and had previously 
provided consent were eligible to participate in this 
survey. An adult household representative (18 years or 
older) needed to provide additional written informed 
consent before the household could be included in the 
survey. Other details on inclusion criteria and rationale 
for participant selection were published previously.10
The study was approved by the Oxford University 
Tropical Research Ethics Committee (31-15), and the local 
ethical committees of each participating study site.10 
Written informed consent was obtained from participants 
(suppliers and community members) in all data collection 
activities (mapping, household survey, customer exit 
interview, in-depth interviews, and focus group 
discussions).
Quantitative analysis 
Data were collected using tablets and stored using a 
web-based application: Research Electronic Data Capture. 
Data were extracted, cleaned, and analysed in R 
version 3.3.3. Descriptive data were described as mean 
(SD), median (IQR), and proportion (95% CI). The 
analysis and presentation of the quantitative data followed 
the STROBE guidelines for reporting observational 
studies.11 We used a generalised linear model to examine 
the factors associated with family use of antibiotics 
and estimated the adjusted odds ratios (ORs) and their 
95% CIs. Community antibiotic consumption was 
estimated in defined daily doses supplied according to 
WHO’s 2019 AWaRe (Access, Watch, and Reserve) 
classification.12 The factors associated with the supply of 
Watch antibiotics were examined using multivariable 
logistic regression analysis.
For each of the studied communities, through observed 
metrics, we aimed to map all formal and informal 
suppliers of antibiotics, inventory antibiotic resources, 
and determine community antibiotic exposure and the 
appropriateness of the antibiotics supplied. Through 
reported experiences, we aimed to assess demographic, 
socioeconomic, and cultural charac teristics, the accessi-
bility of health care, and frequency of antibiotic intake 
and characterise the practices involved in antibiotic 
demand, access, and use (eg, indication, source, 
knowledge, and expectations).
Qualitative analysis 
A thematic analytical approach was used on the English 
language summaries of each in-depth interview and 
focus group discussion for each study site. Because all 
the interviews and discussions were done in local 
languages, these summaries were made to facilitate 
centralised comparative analysis. The summaries were 
produced when the transcript was coded following a 
standardised format. The analysis was based on a-priori 
themes from the various topics that had been covered 
during the in-depth interviews and focus group 
discussions, with additional themes and subthemes 
emerging inductively during the reading and analysis 
process. Verification of the data and themes was done by 
members of the research team with skills in qualitative 
analysis (NTTD, MG, JJ-L, PA, and JK). This verification 
involved validating and assessing the trustworthiness of 
the qualitative data using the four constructs of credibility, 
transferability, dependability, and conformability.10 The 
analysis was facilitated by QRS International NVivo 
(version 12) software. The analysis and presentation of 
For Research Electronic Data 
Capture see https://www.
project-redcap.org
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the qualitative data followed COREQ guidelines for 
reporting qualitative research.13
Through reported experiences, we aimed to 
investigate health-care concepts and behaviours and 
socioeconomic and cultural characteristics associated 
with practices of antibiotic access and use in each 
studied context.
Role of the funding source 
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing 
of the report.
Results 
Supplier mapping showed that Asian sites had a higher 
density of antibiotic suppliers than African sites, with 
the highest density found in urban Thailand (5 per 
1000 inhabitants) and the lowest in rural South Africa 
(1 per 10 000 inhabitants; table 1). In Asia, more than 
90% of mapped suppliers were private providers: 
467 (93%) of 502 in Vietnam, 278 (92·4%) of 301 in 
Bangladesh, and 278 (95%) of 293 in Thailand. Ghana had 
a similarly high percentage of private providers (98 [80%] 
of 122), whereas Mozambique (18 [38%] of 47) and South 
Africa (3 [20%] of 15) had lower percentages. Vietnam 
(325 [65%] of 502) and Bangladesh (156 [52%] of 301) had 
the highest proportion of providers operating without 
legal authorisation (non-licensed providers) compared 
with other countries (10 [21%] of 47 in Mozambique, 
five [4%] of 122 in Ghana, 0 [0%] of 2913 Thailand, and 
0 [0%] of 15 in South Africa; table 1).
8214 exit interviews were done with customers who 
purchased antibiotics at 140 suppliers (appendix p 3). The 
proportions of antibiotics dispensed without prescription 
were greater in the low-income and lower middle-income 
countries (1168 [36·1%] of 3237 for Ghana, 844 [45·7%] of 
1859 for Bangladesh, and 773 [55·2%] of 1399 for Vietnam) 
compared with upper middle-income countries (18 [3·9%] 
of 462 for Thailand and five [1·2%] of 418 for South Africa). 
An exception was Mozambique, which was a low-income 
country with a relatively small proportion of antibiotics 
purchased without prescription (67 [8·0%] of 839). Across 
sites, the average proportion of antibiotics dispensed 
without prescription was 2875 (35·0%) of 8214 interviewed 
customers.
6190 households with 25 274 individuals were assessed 
for their practices regarding antibiotic access and use 
(appendix pp 4–5). Across sites, 2290 (37·0%) households 
reported self-treatment with antibiotics. For mild illness, 
drug stores in Vietnam (2630 [72·5%] of 3627) and 
Low-income countries Lower middle-income countries Upper middle-income countries
Bangladesh Mozambique Vietnam Ghana Thailand South Africa
Site name Matlab Manhica Filabavi Dodowa; Kintampo Kanchanaburi Agincourt
Site population 225 000 165 346 262 000 117 341; 142 977 59 966 120 000
Under-5 mortality per 1000 livebirths (year) 37·4 (2011) 76·1 (2014) 8·4 (2011) 32·8 (2011); 62·6 (2011) 8·5 (2009) 48·0 (2009)
Number of antibiotics suppliers 301 47 502 122* 293 15
Non-licensed, n (%) 156 (52%) 10 (21%) 325 (65%) 5 (4%)* 0 0
Private, n (%) 278 (92%) 18 (38%) 467 (93%) 97 (80%)* 278 (95%) 3 (20%)
*Mean data for both sites are presented. Separate data for each site are provided in the appendix (p 11).
Table 1: Key demographic indicators and antibiotic access at surveyed sites
Bangladesh Mozambique Vietnam Ghana Thailand South Africa
In mild illness
N* 4424 985 3627 9742 3707 2422
Drug store 4024 (91·0%)† 57 (5·8%) 2630 (72·5%)† 4967 (51·0%)† 1548 (41·8%)† 10 (0·4%)
Private facility 36 (0·8%) 35 (3·6%) 241 (6·6%) 978 (10·0%) 1134 (30·6%) 90 (3·7%)
Public facility 327 (7·4%) 797 (80·9%)† 411 (11·3%)‡ 2840 (29·2%) 920 (24·8%) 2303 (95·1%)†
Other 37 (0·8%) 96 (9·7%) 347 (9·5%) 957 (9·8%) 105 (2·8%) 19 (0·8%)
In severe illness
N* 4419 984 3629 9746 3706 2422
Drug store 28 (0·6%) 9 (0·9%) 5 (0·1%) 218 (2·2%) 2 (0·1%) 8 (0·3%)
Private facility 1672 (37·8%) 29 (2·9%) 841 (23·2%) 1714 (17·6%) 590 (15·9%) 126 (5·2%)
Public facility 2716 (61·5%)† 907 (92·2%)† 2690 (74·1%)†‡ 7111 (73·0%)† 3093 (83·5%)† 2275 (93·9%)†
Other 3 (0·1%) 39 (4·0%) 93 (2·6%) 703 (7·2%) 21 (0·6%) 13 (0·5%)
Data are n (%), unless otherwise specified. *The number of responses for the most common first point of contact for the individual household members in each site. †Most 
common first point of contact. ‡Includes communal health stations.
Table 2: Care-seeking behaviours among households included in the household survey—first point of contact when household members were unwell
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Bangladesh (4024 [91·0%] of 4424) and public health-care 
facilities in Mozambique (797 [80·9%] of 985) and 
South Africa (2303 [95·1%] of 2422) were the 
predominant first point of contact for household 
members (table 2). Drug stores were also the most 
common point of contact when seeking antibiotics for 
children with mild illness in all countries, except for 
Vietnam, where the drug store was a more common first 
point of contact when purchasing antibiotics for adults 
(1991 [79·7%] of 2498) than when purchasing for children 
(638 [56·6%] of 1127).
Qualitative analysis showed that, although public health-
care facilities were predominantly chosen for more severe 
illness in all countries, drug stores were the first point of 
contact for treatment of mild symptoms in most settings, 
except Mozambique and South Africa. In in-depth 
interviews and focus group discussions with community 
members, most people in South Africa and Mozambique 
reported that they relied on treatment from primary health-
care facilities, including antibiotics, which were provided 
for free. However, in Mozambique, when drugs were 
unavailable at health-care facilities, people could acquire 
them from private pharmacies where antibiotics are more 
costly.
From in-depth interviews and focus group discussions, 
factors determining where treatment was sought for a 
household often involved policy-associated determinants 
and a balance between trust in the supplier and the drug, 
Panel: Demand-side factors associated with antibiotic access and use shared by studied communities
Care seeking behaviour 
Policy-associated behaviour 
“Here in South Africa, you cannot get antibiotics without the 
referral from the doctor.” (focus group discussion 1, woman, 
30 years, South Africa)
“If I want to buy Yaa Chud [poly-pharmaceutical packs 
containing antibiotics], I just walk to the grocery shop nearby.” 
(in-depth interview 13, woman, 68 years, Thailand)
Perception of health-care facilities 
“It’s not difficult to get to the hospital, the biggest problem is 
the delay to be seen, and sometimes the lack of pills at the 
hospital, what compels us to buy at the private pharmacy where 
[antibiotics] are so expensive and we do not have money to 
pay.” (focus group discussion 4, man, 30–45 years, 
Mozambique)
“The treatment is for free but people are hesitant to use it. 
Instead they want something that they will pay for.” (in-depth 
interview 2, man, 64 years, South Africa)
“I would like to take treatment in government hospital, but I 
don’t get proper service there. They don’t do their assigned 
duty, neglect the patients.” (focus group discussion 6, man, 
30–45 years, Bangladesh)
Trust in supplier 
“When I have mild symptoms, I always go to the drug store first. I 
don’t even know the name [of the medications] and their effect 
because I trust them completely. I only go to the hospital when I 
get more severe illness.” (focus group discussion 7, woman with 
children younger than 5 years, 25 years, Vietnam)
Convenience of access 
“I prefer buying medicine from a nearby drug store than going 
to the hospital. At the pharmacy, they ask the symptoms before 
they give the drugs and they are very effective.” (focus group 
discussion 4, woman, 32 years, Ghana)
“Most people don’t like going to the hospital. When they visit 
the hospital, they will sit there for a very long time before they 
are attended to, so patients may end up dying with the illness 
they took to the hospital. So they will move straight to the drug 
store to buy medicines to cure their illness.” (focus group 
discussion 6, woman, 29 years, Ghana)
Perceived disease severity 
“Our family members did not like to go see a doctor, except when 
we got a serious sickness. If someone has a fever or cough, we buy 
Yaa Chud [non-prescribed poly-pharmaceutical packs containing 
antibiotics] from the drug store.” (in-depth interview 6, woman 
with children younger than 5 years, 36 years, Thailand)
“I only go to the hospital when I get more severe illness.” (focus 
group discussion 1, woman with children younger than 5 years, 
38 years, Vietnam)
Children are a priority 
“If children are sick, it is a must to bring them to hospital.” (focus 
group discussion 5, woman, 35 years, Vietnam)
Perception of antibiotics 
Misperception of antibiotics’ function 
“Antibiotics are powerful drugs, which are used for serious 
illnesses. When paracetamol does not work for cough and cold 
then antibiotics should be used.” (focus group discussion 7, 
woman with children younger than 5 years, 21 years, Vietnam)
“Recently, febrile illness could not be cured without antibiotics, 
and I have to spend thousands BDT [Bangladesh currency] 
every month for buying antibiotics”. (focus group discussion 1, 
man, 50 years, Bangladesh)
“People are not dying like in the past; it means they are using 
antibiotics in a good way.” (focus group discussion 8, woman, 
21–30 years, South Africa)
Confusion of antibiotic with anti-inflammatory 
“We don’t know them by name. They have two colours.” 
(focus group discussion 4, man, 42 years, Mozambique)
“There are different types of antibiotics. We have the red and 
yellow [amoxicillin] that is used for stomach pains and wounds. 
There is a different type that is red it is also used for waist 
pains.” (focus group discussion 2, woman, 27 years, Ghana)
(Continues on next page)
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convenience of access, disease severity, and whether or 
not the consumer was a child (panel). Where regulations 
were more enforced, community members were aware 
that it was not permitted to buy antibiotics directly 
from the pharmacy without prescription (South Africa). 
Although antibiotics were highly regulated by national 
policies at authorised suppliers in Thailand, they were 
still illegally distributed by unauthorised dispensers. In 
in-depth interviews with community members, the main 
concern regarding illegally distributed antibiotics was so-
called Yaa Chud (poly-pharmaceutical packs containing 
antibiotics), which are widely available in community-
based grocery stores. In low-income and lower middle-
income countries, where the regulation was less likely to 
be enforced, participants indicated that self-treatment 
was less time consuming, cheaper, and overall, more 
convenient than the public health services, corroborating 
what we found in the quantitative results.
In household surveys, most respondents said they 
chose where to access antibiotics for mild illness on the 
basis of how convenient the location was to access, except 
Mozambique, where trust was the most common reason 
for choosing a public health-care facility (figure 1). For 
severe illness, trust was among the most common 
reasons for choosing a public facility, except in Thailand. 
Convenience was the most common reason for 
South Africa and Thailand, whereas disease severity was 
the most common for Vietnam and Ghana.
In Bangladesh, participants in focus group discussions 
shared that public health services at the district level or 
lower are free of charge but are considered low standard, 
with few types of antibiotics available. Therefore, 
community members mainly rely on nearby drug sellers 
(those commonly perceived as doctors by local people) 
for mild conditions. In Ghana, the main and first 
approached sources for antibiotics were licensed 
chemical sellers (over-the-counter medicine sellers who 
are not allowed by regulations to sell antibiotics other 
than co-trimoxazole) and drug peddlers (street vendors 
who sell drugs illegally). Findings from focus group 
discussions suggested that delays in receiving care at 
hospitals encouraged people to seek medicine from the 
licensed chemical sellers rather than from public health-
care providers (panel). This common reason was also 
reported in Vietnam, where there is a high density of 
private and non-licensed antibiotic suppliers.
The largest proportion of households reporting use of 
antibiotics in the previous month in the first household 
survey was in Bangladesh (498 [49·4%] of 1009), followed 
by Vietnam (416 [45·0%] of 925), Ghana (728 [37·4%] of 
1947), Thailand (294 [27·9%] of 1053), Mozambique 
(161 [25·2%] of 639), and South Africa (63 [10·2%] of 616; 
table 3). These proportions were similar in the second 
round. However, the proportions of antibiotic use 
without prescription in the second round were 
substantially decreased in Mozambique and increased in 
Ghana compared with the first round (appendix p 8). 
Households without health insurance coverage were less 
likely to have used antibiotics (adjusted OR 0·82, 95% CI 
0·70–0·96). Having access to drug stores for health care 
(1·26, 1·07–1·47) and for information (1·17, 1·03–1·33) 
increased household antibiotic use. In the repeated 
survey, apart from site and number of household 
members, reported antibiotic use in the first round (1·38, 
1·19–1·59; p<0·0001) and getting information from drug 
stores (1·29, 1·03–1·62; p=0·031) was significantly 
(Panel continued from previous page)
“I know some [antibiotics] such as ‘Amox’ [amoxicillin], ‘Tiffy’ 
[paracetamol], ‘Panadol’ [paracetamol], ‘anpha choay’ [anpha-
chymotripsin].” (focus group discussion 1, woman with child 
younger than 5 years, 21 years, Vietnam)
Limited knowledge of antibiotic resistance 
“I find that illness resolves after consuming antibiotics very 
quickly, but I think it creates another disease in our body and 
gives rise to side-effects. People are not aware of this properly.” 
(focus group discussion 2, woman, 40 years, Bangladesh)
“Recently, many people in my village have had common cold or 
flu due to the changing season. The disease has been more 
severe and difficult to treat as it has become resistant to flu 
medicines. Higher doses of antibiotics were, therefore, needed 
to recover.” (focus group discussion 8, man, 65 years, Vietnam)
Practice 
Self-treatment linked to previous experience 
“If you have previously used an antibiotic, you just go and buy 
one from the drug store. Recently, I bought some antibiotics 
(Amoxicillin), because I knew what I wanted [so] I just went to 
the drug store and asked for it.” (in-depth interview 10, 
woman, 20 years, Ghana)19
Taking incomplete courses 
“I won’t deny it, sometimes I also do that [laughing], I take pills 
and when I see I am better, especially if the pills are bitter, I stop 
taking them, I quit.” (focus group discussion 1, woman, 
18–30 years, Mozambique)
“They prescribe drug for me to buy some medicine, but I 
couldn’t buy all the medicine, so I bought some of the medicine, 
and 2 weeks later, I bought the rest of the medicine that time all 
my feet got swollen.” (in-depth interview 16, woman, 21 years, 
Ghana)
Shared with others or save for future use 
“I share medicines with my neighbours and I usually ask them 
for Napa [paracetamol], peridon [domperidone], and 
antibiotics for dysentery.” (in-depth interview 1, man, 40 years, 
Bangladesh)
“We keep them so that we can use them again when we get ill.” 
(focus group discussion 4, woman, 18–26 years, South Africa)
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associated with the reported use in the second round 
(appendix p 12). The proportion of households self-
treating with antibiotics varied from zero (0·0%) of 72 in 
South Africa to 448 (65·3%) of 686 in Bangladesh in the 
first survey. In the second survey, this proportion was 
increased for Ghana (532 [70·6%] of 754; p<0·0001) but 
reduced for Mozambique (two [1·4%] of 139; p<0·0001), 
and it remained similar for other countries (appendix p 8).
Misperceptions about antibiotics were common 
among respondents in the household survey, especially 
confusion about what antibiotics do and when they 
should be taken (appendix p 6). Antibiotics were bought 
for different indications across the surveyed countries. 
Indications commonly reported in exit interviews and 
household surveys included respiratory (cough), 
systemic (fever), and gastrointestinal symptoms (in 
Ghana only; figure 2). More antibiotics were purchased 
for upper-respiratory symptoms in Vietnam (767 [53%] 
of 1457 purchases for cough and 675 [46%] for throat) 
and for fever in Bangladesh (874 [46%] of 1897) than in 
other countries in exit interviews. However, obtaining 
antibiotics for gastrointestinal symptoms was more 
common in Ghana (1253 [35%] of 3600 purchases 
overall, 1046 [41%] of 2521 in Kintampo and 207 [19%] of 
1079 in Dodowa) than in the other sites. More 
participants in Thailand reported purchasing antibiotics 
for skin wounds (100 [19%] of 525 purchases) than in 
other countries.
Across sites, both suppliers (in-depth interviews) 
and consumers (household surveys) could not always 
distinguish antibiotics from other commonly sold 
medicines like painkillers (eg, tramadol) or antipyretics. 
Antibiotics were often identified by colour and shape, 
such as red and green capsules or pink elongated pills. 
The wide variety in names and appearances contributed 
to potential misidentification (appendix p 7). Medications 
dispensed as capsules were regularly considered to be 
antibiotics, despite the fact that this is neither exclusive 
nor universal for antibiotics.
Across all sites, it was commonly reported in focus group 
discussions that antibiotics were used for similar conditions 
as found in the quantitative results. Participants in 
Bangladesh, Mozambique, and Vietnam thought antibiotics 
were medications for most diseases, including infections 
that were probably non-bacterial. In African sites, malaria 
and sexually transmitted infections were more commonly 
indicated conditions. Regardless of perceived treatable 
conditions, antibiotics were considered to be powerful and 
life-saving medicine across both continents (panel).
Access-group antibiotics were predominant in almost 
all sites (ranging from 3664 [50·7%] of 7222 defined daily 
doses in Vietnam to 1764 [84·6%] of 2052 defined daily 
doses in South Africa), except Bangladesh, where the 
Watch-group antibiotics accounted for 7414 (74·6%) of 
9934 defined daily doses (appendix pp 9–10). No Reserve-
group antibiotics were supplied at any of the study sites.
Qualitative findings from in-depth interviews and focus 
group discussions with community members showed that 
antibiotic use without prescription was a common practice 
in almost all sites except South Africa. It was commonly 
reported to be based on previous treatment experience.
Community members were not aware that antibiotic 
courses should be completed and that antibiotics can be 
harmful to their body. In low-income countries, lack of 
money forces community members to buy incomplete 
courses of treatment. Even when people could afford a 
full course, they still bought a few pills to see if they 
worked (ie, pills were sold in small numbers or doses). 
In South Africa where patients received full courses 
prescribed by health-care workers, patients did not 
always complete their courses, because they did not feel 
the need to take more pills after they recovered. Unused 
Figure 1: Reasons for choosing the selected first point of contact in case of mild and severe illness for household members
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medicines were shared with others or saved for future 
use in almost all sites but could be returned and refunded 
in Bangladesh, Ghana, and Vietnam (panel).
Discussion 
Our results showed that a large proportion of antibiotics 
were acquired without a prescription across study sites 
in low-income and lower middle-income countries. 
2875 (35·0%) of the 8214 customers interviewed across 
all six countries had purchased antibiotics without a 
prescription. This finding aligned with those from 
the household survey, in which 2290 (37·0%) of 
6190 households reported self-medication with anti-
biotics. Despite the legal requirements to dispense 
antibiotics only with prescription, non-compliance was 
found to be widespread in the low-income and lower 
middle-income countries, but not in the two upper 
middle-income countries. This non-compliance could be 




Bangladesh 498/1009 (49·4%) 511/1009 (50·6%) 1 (ref) ··
Mozambique 161/639 (25·2%) 478/639 (74·8%) 0·59 (0·46–0·75) <0·0001
Vietnam 416/925 (45·0%) 509/925 (55·0%) 0·71 (0·56–0·89) 0·0038
Ghana (Kintampo) 465/1100 (42·3%) 635/1100 (57·7%) 0·73 (0·57–0·94) 0·014
Ghana (Dodowa) 263/847 (31·1%) 584/847 (68·9%) 0·50 (0·39–0·65) <0·0001
Thailand 294/1053 (27·9%) 759/1053 (72·1%) 0·50 (0·39–0·64) <0·0001
South Africa 63/616 (10·2%) 553/616 (89·8%) 0·21 (0·15–0·29) <0·0001
Number of people in the household
1–4 1050/3553 (29·6%) 2503/3553 (70·4%) 1 (ref) ··
>4 1108/2624 (42·2%) 1516/2624 (57·8%) 1·00 (1·00–1·00) 0·38
Sex of respondent
Male 592/1853 (31·9%) 1261/1853 (68·1%) 1 (ref) ··
Female 1559/4314 (36·1%) 2755/4314 (63·9%) 1·09 (0·99–1·20) 0·082
Highest education level in the family
Secondary school or 
higher
1706/4727 (36·1%) 30 201/4727 (63·9%) 1 (ref) ··
Primary school or less 454/1462 (31·1%) 1008/1462 (68·9%) 0·95 (0·84–1·06) 0·34
Health-care coverage
Free health insurance 963/2937 (32·8%) 1974/2937 (67·2%) 1 (ref) ··
Paid health insurance 388/1094 (35·5%) 706/1094 (64·5%) 0·98 (0·84–1·13) 0·76
Out-of-pocket payment 809/2158 (37·5%) 1349/2158 (62·5%) 0·82 (0·70–0·96) 0·013
Health-care options available to the household
Public hospitals 965/3208 (30·1%) 2243/3208 (69·9%) 1 (ref) ··
Private hospitals 632/1782 (35·5%) 1150/1782 (64·5%) 1·13 (0·97–1·32) 0·11
Drug stores 419/822 (51·0%) 403/822 (49·0%) 1·26 (1·07–1·47) 0·0054
Other options 144/377 (38·2%) 233/377 (61·8%) 1·16 (0·86–1·57) 0·33
Drug supplier household members attended
Public hospitals 1011/3311 (30·5%) 2300/3311 (69·5%) 1 (ref) ··
Private hospitals 473/1336 (35·4%) 863/1336 (64·6%) 0·96 (0·83–1·13) 0·64
Drug stores 487/1086 (44·8%) 599/1086 (55·2%) 0·96 (0·82–1·13) 0·64
Other suppliers 189/456 (41·4%) 267/456 (58·6%) 1·21 (0·91–1·61) 0·19
Factors determines choices of drug supplier
Convenience 612/1782 (34·3%) 1170/1782 (65·7%) 1 (ref) ··
Trust 846/2320 (36·5%) 1474/2320 (63·5%) 1·01 (0·90–1·14) 0·81
Cost 491/1501 (32·7%) 1010/1501 (67·3%) 1·02 (0·89–1·16) 0·79
Other factors 211/586 (36·0%) 375/586 (64·0%) 0·95 (0·77–1·17) 0·64
Source of information
Health-care facilities 495/1817 (27·2%) 1322/1817 (72·8%) 1 (ref) ··
Drug stores 798/1969 (40·5%) 1171/1969 (59·5%) 1·17 (1·03–1·33) 0·016
Print materials 163/540 (30·2%) 377/540 (69·8%) 1·23 (1·02–1·50) 0·034
Other sources 704/1863 (37·8%) 1159/1863 (62·2%) 1·07 (0·94–1·23) 0·32
Knowledge about antibiotics, number of correct answers out of 4
0 226/1073 (21·1%) 847/1073 (78·9%) 1 (ref) ··
1 746/1979 (37·7%) 1233/1979 (62·3%) 1·43 (1·23–1·67) <0·0001
2 340/830 (41·0%) 490/830 (59·0%) 1·66 (1·38–1·99) <0·0001
3 353/951 (37·1%) 598/951 (62·9%) 1·65 (1·37–1·98) <0·0001
4 482/1315 (36·7%) 833/1315 (63·3%) 1·54 (1·28–1·85) <0·0001
Other comparisons across the two sites in Ghana are presented in the appendix (appendix p 11). OR=odds ratio. 
*ORs are adjusted using a generalised linear model that include all the listed variables.
Table 3: Family use of antibiotics in the previous month in the first survey round and associated factors
Figure 2: Reported indications for antibiotics obtained at drug suppliers 
through exit interviews and reported antibiotic use by household members 
in the past month, obtained through household surveys
Bars represent counts of individuals with specific indication, counts are not 
mutually exclusive except for the “Others” category. Respiratory category 
includes throat, cough, nose, chest pain, and dyspnoea symptoms. Systemic 
category includes headache, non-localised pain, weakness, and fever symptoms. 
Genitourinary category includes sexually transmitted infections, gynaecological, 
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a focus of future interventions, which will require 
context-adjusted models for optimal effect. In rural 
South Africa, for example, little health care was available 
and a clear governance structure that made antibiotics 
accessible only through prescription was adhered to, 
limiting access. Additional factors also limited access in 
South Africa, including ability to reach and to pay.14 One 
exception was rural Mozambique, a low-income country 
with a relatively small proportion of antibiotics purchased 
without prescription (67 [8·0%] of 839), caused not 
by better enforcement but rather by limited access, 
as well as availability of free health care provided by 
clinical studies to participating patients.15,16 Our findings 
confirm the common practice of accessing antibiotics 
without prescriptions in LMICs that has previously 
been reported.6,17,18 A common theme was self-treatment 
being less time consuming, cheaper, and overall more 
convenient than using public health services.
Although prescription-only regulations for antibiotics 
might not be practical for many LMICs,19–21 easy access 
to antibiotics, particularly to broad-spectrum antibiotics 
in rural settings in Asia, raises concerns about high 
levels of antibiotic use outside the formal health-care 
system and will require interventions that target both 
the supply and demand sides to reduce inappropriate 
antibiotic use.22,23 Watch-group antibiotics (access to 
which should be restricted in the community) formed 
larger proportions of antibiotic sales in Asian sites 
compared with African sites. Frequent use of Watch 
antibiotics was mainly associated with use for children 
in all Asian sites and purchasing without a prescription 
in Ghana. No Reserve-group antibiotics were dispensed 
at any of the study sites. As reflected in our findings, 
drug stores were the predominant first point of contact 
in case of mild illness owing to convenience, time, 
distance, and cost, whereas trust was the rationale for 
those who chose public services. Even in an 
environment with more heavily enforced policy 
(Thailand), self-medication with unknown medicines 
that include antibiotics (Yaa Chud) is a relatively 
common practice among older adults and migrant 
workers.24 Therefore, the potential conflict of interest, 
in which drug sellers are in the position of offering 
health recommendations to either benefit their 
customers or their own financial profits, needs to 
be addressed. Strengthening capacity of community 
pharma cists and raising their awareness about the role 
of the pharmacist in health-care systems to promote 
prudent antibiotic use in the community are therefore 
crucial.25–27 The role of the public health system, where 
patients chose to go because they trusted the provider 
during severe illness, or out of convenience in case of 
mild illness, should also be recognised. Considering 
the larger population that the public system serves and 
that they normally have no incentive to prescribe and 
sell antibiotics, interventions targeting these facilities 
remain crucial. Providing quality care by educational 
interventions, rapid diagnostic tests, increasing 
insurance coverage, and community sensi tisation could 
lead to better use of public health-care services at the 
grassroots level.28–30
Confusion regarding how to identify oral antibiotics 
was revealed in both Africa and Asia. This issue needs 
to be considered before other issues of demand are 
addressed.31 Community members should be able to 
distinguish an antibiotic from other commonly sold 
medicines, such as painkillers or antipyretics, regardless 
of where they obtain the medicine. Clear labelling 
of antibiotics empowers community members to be 
conscious about use of antibiotics and enables them to 
put any future communication campaign about better 
use of antibiotics into practice. At present, they are reliant 
on information provided by drug sellers, which was often 
inadequate or entirely absent. Lessons can be learnt 
from the Red Line public awareness campaign in India, 
which made it mandatory to display a red vertical band 
on packaging of prescription-only drugs to improve 
identification and awareness of the dangers of antibiotic 
misuse.32 This campaign aligns with the global strategy 
of making communities more resilient in dealing with 
public health emergencies and the trend of involving 
patients more in treatment decisions.
Despite the richness of the data, this study has several 
limitations. First, the study was done in individual rural 
or urban and suburban communities in LMICs and is 
thus not fully representative of misuse of antibiotics 
in each country. Second, we might not have captured 
all antibiotic use, especially without prescriptions, by 
household members due to poor recall, self-perceived 
misuse of antibiotics, or lack of awareness that pills taken 
were antibiotics. Third, our stratified sampling resulted 
in an imbalanced proportion of supplier types owing to 
the small number of formal suppliers versus informal 
suppliers in some sites. Nevertheless, the collected 
information covers all types of suppliers that the 
community members are exposed to. Finally, we 
experienced challenges in approaching non-licensed 
antibiotics suppliers, which predominated in Asia, due to 
their refusal to participate in several study components. 
We might therefore have underestimated the proportion 
of inappropriate antibiotic use.
This study showed that antibiotic use differed 
markedly between study sites in LMICs and that access 
generally appeared to be more restricted in African than 
Asian locations. In Asian sites, antibiotics were widely 
available through a high density of both formal and 
informal antibiotic suppliers, and we found more 
dispensing without a prescription relative to African 
sites. The associated contextual factors will serve as 
targets for development of context-tailored, integrated 
intervention packages that target both the supply and 
demand side, to improve antibiotic use in these settings, 
and will contribute to global efforts to combat antibiotic 
resistance.
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